Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 114

  • Showing results for seo, jong jin. Search instead for Se-Jong Jin (1 item)

The Incidence and Immunophenotypic and Genetic Features of JL1 Expressing Cells and the Therapeutic Potential of an Anti-JL1 Antibody in De Novo Pediatric Acute Leukemias.

Park SH, You E, Park CJ, Jang S, Cho YU, Yoon CH, Koh KN, Im HJ, Seo JJ.

Ann Lab Med. 2019 Jul;39(4):358-366. doi: 10.3343/alm.2019.39.4.358.


Comparison of whole-body MRI, bone scan, and radiographic skeletal survey for lesion detection and risk stratification of Langerhans Cell Histiocytosis.

Kim JR, Yoon HM, Jung AY, Cho YA, Seo JJ, Lee JS.

Sci Rep. 2019 Jan 22;9(1):317. doi: 10.1038/s41598-018-36501-1.


Comparable Outcome with a Faster Engraftment of Optimized Haploidentical Hematopoietic Stem Cell Transplantation Compared with Transplantations from Other Donor Types in Pediatric Acquired Aplastic Anemia.

Kim H, Im HJ, Koh KN, Kang SH, Yoo JW, Choi ES, Cho YU, Jang S, Park CJ, Seo JJ.

Biol Blood Marrow Transplant. 2019 May;25(5):965-974. doi: 10.1016/j.bbmt.2019.01.010. Epub 2019 Jan 11.


αβ T-cell-depleted haploidentical hematopoietic cell transplantation and zoledronate/interleukin-2 therapy in children with relapsed, high-risk neuroblastoma.

Koh KN, Im HJ, Kim H, Kim N, Choi ES, Park CJ, Jang S, Seo JJ.

Bone Marrow Transplant. 2019 Feb;54(2):348-352. doi: 10.1038/s41409-018-0305-3. Epub 2018 Aug 16. No abstract available.


Depletion of αβ+ T cells for a haploidentical hematopoietic stem cell transplantation in children.

Choi ES, Im HJ, Kim H, Koh KN, Jang S, Park CJ, Seo JJ, Park HR.

J Clin Apher. 2018 Aug;33(4):521-528. doi: 10.1002/jca.21634. Epub 2018 Jul 3.


Initial Characteristics and Clinical Severity of Hemophagocytic Lymphohistiocytosis in Pediatric Patients Admitted in the Emergency Department.

Lee JY, Kim JH, Lee JS, Ryu JM, Seo JJ, Im HJ.

Pediatr Emerg Care. 2018 May 23. doi: 10.1097/PEC.0000000000001518. [Epub ahead of print]


Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients.

Kim H, Kang HJ, Park KD, Koh KN, Im HJ, Seo JJ, Lee JW, Chung NG, Cho B, Kim HK, Lee JM, Hah JO, Lee JA, Lee YH, Park SK, Baek HJ, Kook H, Kim JY, Kim HS, Kim HM, Chueh HW, Park M, Yoon HS, Lee MJ, Choi HS, Ahn HS, Kawano Y, Park JW, Hahn S, Shin HY.

Cancer Res Treat. 2019 Jan;51(1):357-367. doi: 10.4143/crt.2017.457. Epub 2018 May 14.


Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.

Gore L, Kearns PR, de Martino ML, Lee, De Souza CA, Bertrand Y, Hijiya N, Stork LC, Chung NG, Cardos RC, Saikia T, Fagioli F, Seo JJ, Landman-Parker J, Lancaster D, Place AE, Rabin KR, Sacchi M, Swanink R, Zwaan CM.

J Clin Oncol. 2018 May 1;36(13):1330-1338. doi: 10.1200/JCO.2017.75.9597. Epub 2018 Mar 2.


Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.

Barzaghi F, Amaya Hernandez LC, Neven B, Ricci S, Kucuk ZY, Bleesing JJ, Nademi Z, Slatter MA, Ulloa ER, Shcherbina A, Roppelt A, Worth A, Silva J, Aiuti A, Murguia-Favela L, Speckmann C, Carneiro-Sampaio M, Fernandes JF, Baris S, Ozen A, Karakoc-Aydiner E, Kiykim A, Schulz A, Steinmann S, Notarangelo LD, Gambineri E, Lionetti P, Shearer WT, Forbes LR, Martinez C, Moshous D, Blanche S, Fisher A, Ruemmele FM, Tissandier C, Ouachee-Chardin M, Rieux-Laucat F, Cavazzana M, Qasim W, Lucarelli B, Albert MH, Kobayashi I, Alonso L, Diaz De Heredia C, Kanegane H, Lawitschka A, Seo JJ, Gonzalez-Vicent M, Diaz MA, Goyal RK, Sauer MG, Yesilipek A, Kim M, Yilmaz-Demirdag Y, Bhatia M, Khlevner J, Richmond Padilla EJ, Martino S, Montin D, Neth O, Molinos-Quintana A, Valverde-Fernandez J, Broides A, Pinsk V, Ballauf A, Haerynck F, Bordon V, Dhooge C, Garcia-Lloret ML, Bredius RG, Kałwak K, Haddad E, Seidel MG, Duckers G, Pai SY, Dvorak CC, Ehl S, Locatelli F, Goldman F, Gennery AR, Cowan MJ, Roncarolo MG, Bacchetta R; Primary Immune Deficiency Treatment Consortium (PIDTC) and the Inborn Errors Working Party (IEWP) of the European Society for Blood and Marrow Transplantation (EBMT).

J Allergy Clin Immunol. 2018 Mar;141(3):1036-1049.e5. doi: 10.1016/j.jaci.2017.10.041. Epub 2017 Dec 11.


Clinical and Cytogenetic Profiles of Rhabdomyosarcoma with Bone Marrow Involvement in Korean Children: A 15-Year Single-Institution Experience.

Lee DH, Park CJ, Jang S, Cho YU, Seo JJ, Im HJ, Koh KN, Cho KJ, Song JS, Seo EJ.

Ann Lab Med. 2018 Mar;38(2):132-138. doi: 10.3343/alm.2018.38.2.132.


Reconstitution of T and NK cells after haploidentical hematopoietic cell transplantation using αβ T cell-depleted grafts and the clinical implication of γδ T cells.

Park M, Im HJ, Lee YJ, Park N, Jang S, Kwon SW, Park CJ, Choi ES, Koh KN, Seo JJ.

Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13147. Epub 2017 Dec 8.


Frequency and Clinicopathologic Features of RUNX1 Mutations in Patients With Acute Myeloid Leukemia Not Otherwise Specified.

You E, Cho YU, Jang S, Seo EJ, Lee JH, Lee JH, Lee KH, Koh KN, Im HJ, Seo JJ, Park YM, Lee JK, Park CJ.

Am J Clin Pathol. 2017 Jul 1;148(1):64-72. doi: 10.1093/ajcp/aqx046.


Hematopoietic stem cell transplantation in pediatric patients with acute myeloid leukemia without favorable cytogenetics.

Suh JK, Lee SW, Koh KN, Im HJ, Choi ES, Jang S, Park CJ, Seo JJ.

Pediatr Transplant. 2017 Nov;21(7). doi: 10.1111/petr.13004. Epub 2017 Aug 1.


The Different Clinical Aspects of Pediatric Primary Airway Tumors in the Larynx, Trachea, and Bronchi.

Cho HJ, Yoon J, Lee E, Lee YS, Kim SY, Roh JL, Kim DK, Choi SH, Park SI, Kim YH, Koh KN, Im HJ, Seo JJ, Hong SJ, Yu J.

J Korean Med Sci. 2017 Aug;32(8):1304-1311. doi: 10.3346/jkms.2017.32.8.1304.


Long-term clinical outcome of spinal Langerhans cell histiocytosis in children.

Lee SW, Kim H, Suh JK, Koh KN, Im HJ, Yoon HM, Seo JJ.

Int J Hematol. 2017 Sep;106(3):441-449. doi: 10.1007/s12185-017-2252-y. Epub 2017 May 17.


Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.

Koh KN, Im HJ, Kim H, Kang HJ, Park KD, Shin HY, Ahn HS, Lee JW, Yoo KH, Sung KW, Koo HH, Lim YT, Park JE, Park BK, Park HJ, Seo JJ.

J Korean Med Sci. 2017 Apr;32(4):642-649. doi: 10.3346/jkms.2017.32.4.642.


Salvage treatment of relapsed/refractory LCH.

Seo JJ.

Blood Res. 2016 Dec;51(4):220-222. doi: 10.5045/br.2016.51.4.220. Epub 2016 Dec 23. No abstract available.


Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey.

Koh KN, Yoo KH, Im HJ, Sung KW, Koo HH, Kim HS, Han JW, Yoon JH, Park HJ, Park BK, Baek HJ, Kook H, Lee JA, Lee JM, Lee KC, Kim SK, Park M, Lee YH, Lyu CJ, Seo JJ.

J Korean Med Sci. 2016 Aug;31(8):1254-61. doi: 10.3346/jkms.2016.31.8.1254. Epub 2016 May 18.


Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy.

Lee JA, Jeon DG, Cho WH, Song WS, Yoon HS, Park HJ, Park BK, Choi HS, Ahn HS, Lee JW, Yoo KH, Sung KW, Koo HH, Kang HJ, Park KD, Shin HY, Koh KN, Im HJ, Seo JJ, Lim YJ, Baek HJ, Kook H.

Pediatr Blood Cancer. 2016 Sep;63(9):1552-6. doi: 10.1002/pbc.26058. Epub 2016 May 16.


Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescents.

Im HJ, Koh KN, Seo JJ.

Blood Res. 2016 Mar;51(1):8-16. doi: 10.5045/br.2016.51.1.8. Epub 2016 Mar 25. Review.

Supplemental Content

Loading ...
Support Center